Security key
98420X103
X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (XFOR)
CUSIP: 98420X103
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 94,372,096
- Total 13F shares
- 10,477,783
- Share change
- +246,762
- Total reported value
- $67,370,946
- Price per share
- $6.43
- Number of holders
- 53
- Value change
- +$1,560,507
- Number of buys
- 27
- Number of sells
- 15
Report period
Q4 2020
Institutions
53
Top holders
10
XFOR full security history
Newer quarter: Q1 2021
Previous quarter: Q3 2020
X4 Pharmaceuticals, Inc SEC filings
X4 Pharmaceuticals, Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420X103
Recent filing periods:
Top shareholders of XFOR - X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
1.7%
|
1,648,485
|
$11,160,000 | — | 30 Sep 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.2%
|
1,086,493
|
$7,356,000 | — | 30 Sep 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1%
|
986,193
|
$6,677,000 | — | 30 Sep 2020 | |
| BVF INC/IL |
13F
|
Company |
0.84%
|
792,892
|
$5,368,000 | — | 30 Sep 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.77%
|
724,680
|
$4,907,000 | — | 30 Sep 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.76%
|
717,392
|
$4,857,000 | — | 30 Sep 2020 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.59%
|
559,494
|
$3,788,000 | — | 30 Sep 2020 | |
| AXA S.A. |
13F
|
Company |
0.58%
|
546,078
|
$3,697,000 | — | 30 Sep 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.45%
|
423,086
|
$2,864,000 | — | 30 Sep 2020 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
0.35%
|
335,000
|
$2,268,000 | — | 30 Sep 2020 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
0.33%
|
311,492
|
$2,109,000 | — | 30 Sep 2020 | |
| SV Health Investors, LLC |
13F
|
Company |
0.33%
|
311,490
|
$2,109,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
242,988
|
$1,645,000 | — | 30 Sep 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.24%
|
231,035
|
$1,565,000 | — | 30 Sep 2020 | |
| FMR LLC |
13F
|
Company |
0.24%
|
221,912
|
$1,502,000 | — | 30 Sep 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.17%
|
156,044
|
$1,056,000 | — | 30 Sep 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.09%
|
83,096
|
$562,000 | — | 30 Sep 2020 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
76,765
|
$520,000 | — | 30 Sep 2020 | |
| Opaleye Management Inc. |
13F
|
Company |
0.08%
|
75,000
|
$508,000 | — | 30 Sep 2020 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.07%
|
67,423
|
$456,000 | — | 30 Sep 2020 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.07%
|
67,197
|
$455,000 | — | 30 Sep 2020 | |
| ZACKS INVESTMENT MANAGEMENT |
13F
|
Company |
0.06%
|
55,931
|
$379,000 | — | 30 Sep 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
51,418
|
$348,000 | — | 30 Sep 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
49,153
|
$333,000 | — | 30 Sep 2020 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.05%
|
45,700
|
$309,000 | — | 30 Sep 2020 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.04%
|
40,167
|
$272,000 | — | 30 Sep 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.04%
|
38,269
|
$260,000 | — | 30 Sep 2020 | |
| Bleichroeder LP |
13F
|
Company |
0.04%
|
35,730
|
$242,000 | — | 30 Sep 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
32,500
|
$220,000 | — | 30 Sep 2020 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.03%
|
26,919
|
$182,000 | — | 30 Sep 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
23,541
|
$159,000 | — | 30 Sep 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
18,010
|
$122,000 | — | 30 Sep 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
17,588
|
$119,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
16,834
|
$114,000 | — | 30 Sep 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
15,709
|
$106,000 | — | 30 Sep 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
13,190
|
$89,000 | — | 30 Sep 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
12,034
|
$81,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
11,149
|
$75,000 | — | 30 Sep 2020 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.01%
|
10,429
|
$71,000 | — | 30 Sep 2020 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.01%
|
10,350
|
$70,000 | — | 30 Sep 2020 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
9,614
|
$65,000 | — | 30 Sep 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
8,632
|
$58,000 | — | 30 Sep 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
8,172
|
$55,000 | — | 30 Sep 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
6,901
|
$47,000 | — | 30 Sep 2020 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
3,603
|
$24,392 | — | 30 Sep 2020 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
1,920
|
$13,000 | — | 30 Sep 2020 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,423
|
$10,000 | — | 30 Sep 2020 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
987
|
$7,000 | — | 30 Sep 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
773
|
$5,000 | — | 30 Sep 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
746
|
$5,000 | — | 30 Sep 2020 |
Institutional Holders of X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (XFOR) as of Q4 2020
As of 31 Dec 2020,
X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (XFOR) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,477,783 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, ORBIMED ADVISORS LLC, BlackRock Inc., Ikarian Capital, LLC, BVF INC/IL, VANGUARD GROUP INC, AXA S.A., RA CAPITAL MANAGEMENT, L.P., STATE STREET CORP, and New Leaf Venture Partners, L.L.C..
This page lists
53
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
50
Q4 2020 holders
53
Holder diff
3
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.